ARCHIVES

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

This article is from The Cancer Letter archive.

Vol. 10 No. 30 | July 27, 1984

Download PDF Visit The Full Archive

Related Articles

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis

March 13, 1987

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001